- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/4462 - Non-condensed piperidines, e.g. piperocaine only substituted in position 3
Patent holdings for IPC class A61K 31/4462
Total number of patents in this class: 91
10-year publication summary
|
6
|
3
|
9
|
5
|
8
|
6
|
6
|
2
|
6
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Serina Therapeutics, Inc. | 42 |
5 |
| The Regents of the University of California | 19590 |
4 |
| Glaxosmithkline Intellectual Property (no.2) Limited | 283 |
3 |
| Dainippon Sumitomo Pharma Co., Ltd. | 210 |
3 |
| Dimerix Bioscience Pty Ltd. | 37 |
3 |
| Khondrion IP B.V. | 22 |
3 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 2644 |
2 |
| Shenzhen Salubris Pharmaceuticals Co., Ltd | 84 |
2 |
| Solvotrin Innovations Limited | 2 |
2 |
| Taisho Pharmaceutical Co., Ltd. | 855 |
2 |
| Sorbonne Universite | 1205 |
2 |
| Cyteir Therapeutics, Inc. | 37 |
2 |
| ABM Therapeutics Corporation | 8 |
2 |
| Neophore Limited | 17 |
2 |
| Glaxo Group Limited | 4251 |
1 |
| F. Hoffmann-La Roche AG | 7957 |
1 |
| AstraZeneca AB | 2971 |
1 |
| Centre National de La Recherche Scientifique | 10149 |
1 |
| Board of Regents, The University of Texas System | 5648 |
1 |
| The Regents of the University of Michigan | 4592 |
1 |
| Other owners | 48 |